expertomega3 (Twitter) - ユーザ詳細

expertomega3 (@expertomega3)

投稿
お気に入り
フォロー
フォロワー

投稿一覧（最新100件）

2 0 0 0 OA Lower Circulating Omega-3 Polyunsaturated Fatty Acids Are Associated with Coronary Microvascular Dysfunction Evaluated by Hyperemic Microvascular Resistance in Patients with Stable Coronary Artery Disease

A lower serum EPA/AA ratio may cause coronary microvascular dysfunction in patients with stable coronary artery disease→It was positively correlated with coronary average peak velocity at #hyperemia https://t.co/fNugFcBZVL #Cardiology

2 0 0 0 OA Lower Circulating Omega-3 Polyunsaturated Fatty Acids Are Associated with Coronary Microvascular Dysfunction Evaluated by Hyperemic Microvascular Resistance in Patients with Stable Coronary Artery Disease

#Arteriopatía coronaria→Una ratio EPA/AA sérica baja puede causar disfunción microvascular coronaria→Correlacionó positivamente con la velocidad pico promedio coronaria durante la hiperemia https://t.co/JkHrF6lPsK #Cardiología

9 0 0 0 OA 脳・神経機能維持とn-3系脂肪酸

RT @NMCerebral: Reviews: Search for Novel Physiological/Pharmacological Actions of n-3 Fatty Acids and Its Future Prospect n-3 fatty acids…

3 0 0 0 OA Low Serum Levels of EPA are Associated with the Size and Growth Rate of Abdominal Aortic Aneurysm

Low serum levels of EPA are associated with the size and growth rate of abdominal aortic aneurysm https://t.co/xSuBHm431Y #Atherosclerosis

3 0 0 0 OA Low Serum Levels of EPA are Associated with the Size and Growth Rate of Abdominal Aortic Aneurysm

Bajos niveles séricos de EPA: Asociados con el tamaño y crecimiento del #aneurisma de la aorta abdominal https://t.co/PMSpnAhFS9

1 0 0 0 OA Aspirin and Eicosapentaenoic Acid May Arrest Progressive IgA Nephropathy: A Potential Alternative to Immunosuppression

Aspirin and eicosapentaenoic acid may arrest progressive immunoglobulin A #nephropathy without the use of steroids https://t.co/1ahbLC6rda

1 0 0 0 OA Aspirin and Eicosapentaenoic Acid May Arrest Progressive IgA Nephropathy: A Potential Alternative to Immunosuppression

El ác. acetilsalicílico y eicosapentaenoico frenan la #nefropatía progresiva por immunoglobulina A sin esteroides https://t.co/yq0msa297O

1 0 0 0 OA Effects of Docosahexaenoic Acid on the Endothelial Function in Patients with Coronary Artery Disease

Arteriopatía coronaria → una baja concentración sérica DHA puede ser un biomarcador predictivo disfunción endotelial http://t.co/hR6YlDD2Bv

1 0 0 0 OA Effects of Docosahexaenoic Acid on the Endothelial Function in Patients with Coronary Artery Disease

Coronary artery disease → a low serum level of DHA may be a predictive biomarker for endothelial dysfunction http://t.co/4v2AtoW5R1

2 0 0 0 OA Relationships between Plasma Fatty Acid Composition and Coronary Artery Disease

Una proporción EPA/AA >0,75 se asocia con un número menor de eventos coronarios mayores en una población japonesa http://t.co/b5lwH3UVJ5

2 0 0 0 OA Relationships between Plasma Fatty Acid Composition and Coronary Artery Disease

An EPA/AA ratio >0.75 has been associated with significantly lower major coronary events in a Japanese population http://t.co/LySPTctpfC

1 0 0 0 OA The Assessment of Risk for Gastrointestinal Injury with Anticoagulant and Antiplatelet Drugs: The Possible Beneficial Effect of Eicosapentaenoic Acid for the Risk of Gastrointestinal Injury

EPA en tratamiento antiplaquetario: Puede alcanzarse la acción antiplaquetaria sin incrementar el riesgo hemorrágico http://t.co/FVzQVQFmpw

1 0 0 0 OA The Assessment of Risk for Gastrointestinal Injury with Anticoagulant and Antiplatelet Drugs: The Possible Beneficial Effect of Eicosapentaenoic Acid for the Risk of Gastrointestinal Injury

EPA added to an antiplatelet therapy: Antiplatelet activity can be obtained without increasing the hemorrhagic risk http://t.co/8RUNW8FBAg

1 0 0 0 OA The Assessment of Risk for Gastrointestinal Injury with Anticoagulant and Antiplatelet Drugs: The Possible Beneficial Effect of Eicosapentaenoic Acid for the Risk of Gastrointestinal Injury

EPA (vs. other antithrombotic drugs) provides a safe means of suppressing or preventing gastrointestinal injury http://t.co/DALgJw1b8J

1 0 0 0 OA The Assessment of Risk for Gastrointestinal Injury with Anticoagulant and Antiplatelet Drugs: The Possible Beneficial Effect of Eicosapentaenoic Acid for the Risk of Gastrointestinal Injury

EPA vs. otros antitrombóticos: Tratamiento con EPA es una forma segura de prevenir o evitar el daño gastrointestinal http://t.co/weYmgUtti8

4 0 0 0 OA Effects of Eicosapentaenoic Acid Treatment on Epicardial and Abdominal Visceral Adipose Tissue Volumes in Patients with Coronary Artery Disease

Consumo oral de EPA purificado, asociado a reducciones en los tejidos adiposos epicárdicos y abdominales-viscerales http://t.co/TTJPGuhrBe

expertomega3 (@expertomega3)

投稿一覧（最新100件）

2 0 0 0 OA Lower Circulating Omega-3 Polyunsaturated Fatty Acids Are Associated with Coronary Microvascular Dysfunction Evaluated by Hyperemic Microvascular Resistance in Patients with Stable Coronary Artery Disease

2 0 0 0 OA Lower Circulating Omega-3 Polyunsaturated Fatty Acids Are Associated with Coronary Microvascular Dysfunction Evaluated by Hyperemic Microvascular Resistance in Patients with Stable Coronary Artery Disease

9 0 0 0 OA 脳・神経機能維持とn-3系脂肪酸

3 0 0 0 OA Low Serum Levels of EPA are Associated with the Size and Growth Rate of Abdominal Aortic Aneurysm

3 0 0 0 OA Low Serum Levels of EPA are Associated with the Size and Growth Rate of Abdominal Aortic Aneurysm

1 0 0 0 OA Aspirin and Eicosapentaenoic Acid May Arrest Progressive IgA Nephropathy: A Potential Alternative to Immunosuppression

1 0 0 0 OA Aspirin and Eicosapentaenoic Acid May Arrest Progressive IgA Nephropathy: A Potential Alternative to Immunosuppression

1 0 0 0 OA Effects of Docosahexaenoic Acid on the Endothelial Function in Patients with Coronary Artery Disease

1 0 0 0 OA Effects of Docosahexaenoic Acid on the Endothelial Function in Patients with Coronary Artery Disease

2 0 0 0 OA Relationships between Plasma Fatty Acid Composition and Coronary Artery Disease

2 0 0 0 OA Relationships between Plasma Fatty Acid Composition and Coronary Artery Disease

1 0 0 0 OA The Assessment of Risk for Gastrointestinal Injury with Anticoagulant and Antiplatelet Drugs: The Possible Beneficial Effect of Eicosapentaenoic Acid for the Risk of Gastrointestinal Injury

1 0 0 0 OA The Assessment of Risk for Gastrointestinal Injury with Anticoagulant and Antiplatelet Drugs: The Possible Beneficial Effect of Eicosapentaenoic Acid for the Risk of Gastrointestinal Injury

1 0 0 0 OA The Assessment of Risk for Gastrointestinal Injury with Anticoagulant and Antiplatelet Drugs: The Possible Beneficial Effect of Eicosapentaenoic Acid for the Risk of Gastrointestinal Injury

1 0 0 0 OA The Assessment of Risk for Gastrointestinal Injury with Anticoagulant and Antiplatelet Drugs: The Possible Beneficial Effect of Eicosapentaenoic Acid for the Risk of Gastrointestinal Injury

4 0 0 0 OA Effects of Eicosapentaenoic Acid Treatment on Epicardial and Abdominal Visceral Adipose Tissue Volumes in Patients with Coronary Artery Disease

お気に入り一覧（最新100件）

フォロー（1138ユーザ）の投稿一覧（直近7日間）

フォロワー（901ユーザ）の投稿一覧（直近7日間）